Saving people from melanoma
one patient at a time
About DigitalDerm
Headquartered in Columbia, S.C., DigitalDerm, Inc. was founded by leading melanoma expert James Grichnik, M.D., Ph.D. His vision was to adapt and upgrade previous total body photography techniques utilizing film and picture books to a computer based system. This would allow all end-users the ability to harness the speed and power of computer generated image display and manipulation. He also wanted it to be easy to use so it would encourage his patients to become an active contributor in the early melanoma detection process.
The company's first commercial offering, MoleMapCD® technology, was developed in conjunction with the Duke Comprehensive Cancer Center in Durham, N.C., where Dr. Grichnik was a researcher and clinician. In use for more than a decade at Duke and other medical facilities, MoleMapCD technology is the new standard of care for documenting the skin of patients at-risk of melanoma and enhancing the ability to identify melanoma in early, more treatable stages.
While MoleMapCD technology has a strong presence in the southeastern United States, DigitalDerm is launching MoleMapCD technology nationwide; exploring international introductions on a country-by-country basis; and developing new, functionality-enhanced releases of its technology.
This web site uses ADxMenu, by studio.aplus
©2008 DigitalDerm™, Inc. All rights reserved
MoleMapCD© is a registered trademark of DigitalDerm™, Inc.